Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating side effect of many cancer treatments. The hallmark of CIPN is degeneration of long axons required for transmission of sensory information; axonal degeneration causes impaired tactile sensation and persistent pain. Currently the molecular mechanisms of CIPN are not understood, and there are no available treatments. Here we show that the chemotherapeutic agent paclitaxel triggers CIPN by altering IP3 receptor phosphorylation and intracellular calcium flux, and activating calcium-dependent calpain proteases. Concomitantly paclitaxel impairs axonal trafficking of RNA-granules and reduces synthesis of Bclw (bcl2l2), a Bcl2 family member that binds IP3R1 and restrains axon degeneration. Surprisingly, Bclw or a stapled peptide corresponding to the Bclw BH4 domain interact with axonal IP3R1 and prevent paclitaxel-induced degeneration, while Bcl2 and BclxL cannot do so. Together these data identify a Bclw-IP3R1-dependent cascade that causes axon degeneration, and suggest Bclw-mimetics could provide effective therapy to prevent CIPN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 1×
“…whether Bcl2 family members are also critical for axon degeneration caused by injury or disease (Cosker et al., 2013; Courchesne et al., 2011; Nikolaev et al., 2009; Pazyra-Murphy et al., 2009; Schoen- 374 Neuron 96, 373–386, October 11, 2017 mann et al., 2010; Simon et al., 2012, 2016;…”
BackgroundRetractedThe versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701 · cited 1×
“Alternatively, early increases in calcium release from intracellular stores may be followed by a homeostatic decrease in IP3-induced calcium release into the cytoplasm (Berridge et al., 2000), resulting in the altered calcium dynamics observed after 24 hr of paclitaxel treatment (Figure 6E).”
BackgroundActivation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Self-citationAxon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · cited 2×
“IP3R1 is also required for axon degeneration induced by other chemotherapeutic agents (Villegas et al., 2014), and alterations in calcium are implicated in axon degeneration due to diverse causes (Coleman, 2005).”
BackgroundStructural biology of the Bcl-2 family of proteins
Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.012 · Cited by 745 · cited 1×
“Although BclxL and Bcl2 full-length proteins or BH4 SAHB domains all bind Bax and prevent Bax-mediated apoptosis (Figures 5E and 6A–6D) (Barclay et al., 2015; Petros et al., 2004), they do not prevent paclitaxel-induced degeneration.”
BackgroundBAX activation is initiated at a novel interaction site
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H.-C., Kim, H., Cheng, E. H.-Y., Tjandra, N., et al. (2008) · Nature · doi:10.1038/nature07396 · Cited by 700 · cited 1×
“Recombinant Bax was generated in BL-21 DE3 E. Coli and then purified by chitin affinity and size exclusion chromatography as described (Edwards et al., 2013; Gavathiotis et al., 2008).”
MethodSelf-citation
Cited by
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Vogler, M., Braun, Y., Smith, V. M., Westhoff, M.-A., Pereira, R. S., Pieper, N. M., Anders, M., Callens, M., Vervliet, T., Abbas, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02176-0 · Cited by 462
Roadmap for the Emerging Field of Cancer Neuroscience
Monje, M., Borniger, J. C., D’Silva, N. J., Deneen, B., Dirks, P. B., Fattahi, F., Frenette, P. S., Garzia, L., Gutmann, D. H., Hanahan, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.034 · Cited by 380
Self-citationThe Calcium-Dependent Protease Calpain in Neuronal Remodeling and Neurodegeneration
Metwally, E., Zhao, G., & Zhang, Y. Q. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.07.003 · Cited by 65
Ando, H., Kawaai, K., Bonneau, B., & Mikoshiba, K. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.12.001 · Cited by 55
Metadata
- Authors
- Pease-Raissi, S. E., Pazyra-Murphy, M. F., Li, Y., Wachter, F., Fukuda, Y., Fenstermacher, S. J., Barclay, L. A., Bird, G. H., Walensky, L. D., & Segal, R. A.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 96
- Issue
- 2
- Pages
- 373-386.e6
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2762020729
- Cited by
- 109
- References
- 6
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration. https://app.cochat.ai/papers/10.1016/j.neuron.2017.09.034
- The paper
- Pease-Raissi, S. E., Pazyra-Murphy, M. F., Li, Y., Wachter, F., Fukuda, Y., Fenstermacher, S. J., Barclay, L. A., Bird, G. H., Walensky, L. D., & Segal, R. A. (2017). Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration. Neuron. https://doi.org/10.1016/j.neuron.2017.09.034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.